Development & Differentiation
CRISPR Applications in Development and Differentiation
Directed differentiation of pluripotent stem cells (PSCs) through the three embryonic germ layers to generate organoids of major human tissues (brain, heart, intestine, liver, lung, etc.), with strategies for functional validation and biomedical applications including disease modeling, drug screening, and personalized medicine.
(Sahu and Sharan.,2020)
Development is orchestrated by a hierarchy of gene regulatory programs — morphogen gradients, signaling crosstalk, chromatin remodeling, and lineage-specifying transcription factors — that transform a single cell into a complete, organized organism.
Errors in these programs cause congenital disorders, developmental defects, infertility, and pediatric disease. Understanding how developmental gene networks operate is therefore central to both basic biology and regenerative medicine.
Traditional approaches could observe developmental phenotypes but rarely establish the causal gene-to-phenotype relationships that drive them. CRISPR-based genome editing enables precise manipulation of developmental regulators, allowing researchers to functionally dissect the programs that build tissues and organs.
CRISPR technology is transforming developmental biology research by enabling:
EDITGENE provides integrated CRISPR solutions covering the complete project chain for developmental research — from pathway analysis and cell model engineering to functional validation.
Embryogenesis converts a fertilized egg into a patterned organism through tightly choreographed events: axis specification, gastrulation, germ layer formation, and organogenesis. CRISPR screening and precision editing allow systematic dissection of the gene networks controlling these foundational events.
Cell fate decisions are driven by lineage-specifying transcription factors, pioneer factors, and chromatin-state transitions that progressively restrict developmental potential. CRISPR activation, interference, and screening approaches allow systematic identification and manipulation of these fate determinants.
Regeneration requires cells to sense injury, re-enter proliferative or reprogrammed states, and rebuild lost structure. Some species regenerate entire organs while mammals show limited capacity — a difference governed by specific genetic programs that CRISPR can systematically probe and reactivate.
Developmental disorders arise from variants that disrupt the gene programs controlling morphogenesis, patterning, and differentiation. CRISPR enables precise introduction of patient variants into defined genetic backgrounds, creating isogenic models that reveal how specific mutations derail development.
From basic discovery to translational research, EDITGENE supports the complete developmental research chain:
| Research Area | Key Scientific Question | CRISPR Strategy | EDITGENE Support |
| Embryogenesis & Organogenesis | Which genes drive embryo and organ formation? | CRISPR KO, CRISPRi/a, screening | Developmental screening, organoid models |
| Lineage Commitment | What determines cell fate decisions? | CRISPRa/i screening, reporter KI | Lineage reporters, iPSC models |
| Regeneration | What enables tissue repair and plasticity? | Activation screening, KO | Injury models, regeneration assays |
| Developmental Disorders | How do variants disrupt development? | Precision knock-in, base editing | Isogenic models, variant analysis |
End-to-End Genome Engineering Solutions — EDITGENE provides reliable CRISPR solutions supporting complete developmental biology programs from research concept to validated models.
Advanced Genome Editing Platforms
Proprietary sgRNA Design Algorithms
Extensive Project Experience
Comprehensive Editing Modes
Stem Cell & Organoid Genome Engineering
Rapid Execution & Flexible Customization
Integrated Workflow
Experienced Team
From mapping the gene networks that build embryos and organs, to identifying cell fate determinants, decoding regeneration, and modeling congenital disease — EDITGENE empowers researchers with reliable CRISPR technology to advance the next generation of developmental biology research.
